2-​[2-​[2-​CHLORO-​3-​[(1,​3-​DIHYDRO-​3,​ 3-​DIMETHYL-​1-​PROPYL-​2H-​ INDOL-​2-​YLIDENE)​ETHYLIDENE]​-​1-​ CYCLOHEXEN-​1-​YL]​ETHENYL]​-​3,​3- ​DIMETHYL-​1-​PROPYLINDOLIUM IODIDE

Suppliers

Names

[ CAS No. ]:
207399-07-3

[ Name ]:
2-​[2-​[2-​CHLORO-​3-​[(1,​3-​DIHYDRO-​3,​ 3-​DIMETHYL-​1-​PROPYL-​2H-​ INDOL-​2-​YLIDENE)​ETHYLIDENE]​-​1-​ CYCLOHEXEN-​1-​YL]​ETHENYL]​-​3,​3- ​DIMETHYL-​1-​PROPYLINDOLIUM IODIDE

[Synonym ]:
11-Chloro-1,1'-di-n-propyl-3,3,3',3'-tetraMethyl-10,12-triMethyleneindatricarbocyanine iodide
IR-780 IODIDE
11-CHLORO-1,1''-DIPROPYL-3,3,3'',3''-TETRAMETHYL-10,12-TRIMETHYLENEINDATRICARBOCYANINE IODIDE
MFCD00191907
IR780
2-​[2-​[2-​CHLORO-​3-​[(1,​3-​DIHYDRO-​3,​ 3-​DIMETHYL-​1-​PROPYL-​2H-​ INDOL-​2-​YLIDENE)​ETHYLIDENE]​-​1-​ CYCLOHEXEN-​1-​YL]​ETHENYL]​-​3,​3- ​DIMETHYL-​1-​PROPYLINDOLIUM IODIDE

Chemical & Physical Properties

[ Melting Point ]:
232-234ºC

[ Molecular Formula ]:
C36H44ClIN2

[ Molecular Weight ]:
667.10500

[ Exact Mass ]:
666.22400

[ PSA ]:
6.25000

[ LogP ]:
6.75170

MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Safety Phrases ]:
S22-S24/25

[ RIDADR ]:
NONH for all modes of transport

Synthetic Route

Articles

Direct chemotherapeutic dual drug delivery through intra-articular injection for synergistic enhancement of rheumatoid arthritis treatment.

Sci. Rep. 5 , 14713, (2015)

The effectiveness of systemic rheumatoid arthritis (RA) treatments is limited by difficulties in achieving therapeutic doses within articular joints. We evaluated the ability of intra-articular admini...


More Articles


Related Compounds

  • 2-{[4-(methoxycarbonyl)-1-methyl-1H-pyrazol-5-yl]oxy}acetic acid
  • 1-Cyanobutane-2-sulfonamide
  • 4-[[2-(2,6-Dioxo-3-piperidyl)-1-oxo-isoindolin-4-yl]carbamoyloxy]-2-hydroxy-butanoic acid
  • N-[2-(2,6-dioxo-3-piperidyl)-1-oxo-isoindolin-4-yl]-3-(p-tolyl)propanamide
  • 3-[2-[2-[2-[[2-(3-Methyl-2,6-dioxo-3-piperidyl)-1,3-dioxo-isoindolin-4-yl]amino]ethoxy]ethoxy]ethoxy]propanoic acid
  • Thalidomide-5'-C3-PEG5-OH
  • methyl 6-[[(1S)-1-[(2S,4R)-4-hydroxy-2-[[4-(4-methylthiazol-5-yl)phenyl]methylcarbamoyl]pyrrolidine-1-carbonyl]-2,2-dimethyl-propyl]amino]-6-oxo-hexanoate
  • N-[2-(2,6-dioxo-3-piperidyl)-1-oxo-isoindolin-4-yl]-3-[2-[2-(2-iodoethoxy)ethoxy]ethoxy]propanamide
  • (2S,4R)-1-[(2S)-2-(6-chlorohexanoylamino)-3,3-dimethyl-butanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methylthiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide
  • (2S,4R)-1-[(2S)-3,3-dimethyl-2-[[2-(2-prop-2-ynoxyethoxy)acetyl]amino]butanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methylthiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide